LivingGLP1
Study S002464

A Randomised, Placebo-Controlled Trial to Evaluate the Effect of Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Who Are Self-Administering GLP-1 Agonists ("Project Zest")

Registration

Registration
NCT07789106
Acronym
Project Zest
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Status
RECRUITING
Enrollment
90
Start
2026-09-01
Primary completion
2027-12-01
Lead sponsor
StudySetGo
Conditions
Obesity & Overweight; GLP - 1; Fatigue Severity Scale; Ubiquinol; Muscle Contraction
Interventions
DIETARY_SUPPLEMENT:Ubiquinol 100 MG Oral Capsule; DIETARY_SUPPLEMENT:Placebo
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Self-reported fatigue [9 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.